A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis - PubMed (original) (raw)
Randomized Controlled Trial
. 2012 Nov;26(11):1719-25.
doi: 10.1002/ptr.4639. Epub 2012 Mar 9.
Affiliations
- PMID: 22407780
- DOI: 10.1002/ptr.4639
Randomized Controlled Trial
A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis
Binu Chandran et al. Phytother Res. 2012 Nov.
Abstract
Curcumin is known to possess potent antiinflammatory and antiarthritic properties. This pilot clinical study evaluated the safety and effectiveness of curcumin alone, and in combination with diclofenac sodium in patients with active rheumatoid arthritis (RA). Forty-five patients diagnosed with RA were randomized into three groups with patients receiving curcumin (500 mg) and diclofenac sodium (50 mg) alone or their combination. The primary endpoints were reduction in Disease Activity Score (DAS) 28. The secondary endpoints included American College of Rheumatology (ACR) criteria for reduction in tenderness and swelling of joint scores. Patients in all three treatment groups showed statistically significant changes in their DAS scores. Interestingly, the curcumin group showed the highest percentage of improvement in overall DAS and ACR scores (ACR 20, 50 and 70) and these scores were significantly better than the patients in the diclofenac sodium group. More importantly, curcumin treatment was found to be safe and did not relate with any adverse events. Our study provides the first evidence for the safety and superiority of curcumin treatment in patients with active RA, and highlights the need for future large-scale trials to validate these findings in patients with RA and other arthritic conditions.
Copyright © 2012 John Wiley & Sons, Ltd.
Similar articles
- Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, Fischkoff SA, Chartash EK. Furst DE, et al. J Rheumatol. 2003 Dec;30(12):2563-71. J Rheumatol. 2003. PMID: 14719195 Clinical Trial. - May etanercept and PTH (1-34) association heal erosions in early rheumatoid arthritis? A pilot study.
Migliore A, Massafra U, Bizzi E, Argento G, Diamanti AP, Germano V, Tormenta S, Arduini F, Iannessi F, Granatas M, Laganà B. Migliore A, et al. Eur Rev Med Pharmacol Sci. 2012 Mar;16(3):363-9. Eur Rev Med Pharmacol Sci. 2012. PMID: 22530354 Clinical Trial. - Differential effect on symptoms treated with traditional Chinese medicine and western combination therapy in RA patients.
He Y, Lu A, Zha Y, Tsang I. He Y, et al. Complement Ther Med. 2008 Aug;16(4):206-11. doi: 10.1016/j.ctim.2007.08.005. Epub 2008 Jan 24. Complement Ther Med. 2008. PMID: 18638711 Clinical Trial. - Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
Ruiz Garcia V, Burls A, Cabello JB, Vela Casasempere P, Bort-Marti S, Bernal JA. Ruiz Garcia V, et al. Cochrane Database Syst Rev. 2017 Sep 8;9(9):CD007649. doi: 10.1002/14651858.CD007649.pub4. Cochrane Database Syst Rev. 2017. PMID: 28884785 Free PMC article. Review. - Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
Ruiz Garcia V, Jobanputra P, Burls A, Cabello JB, Vela Casasempere P, Bort-Marti S, Kynaston-Pearson FJ. Ruiz Garcia V, et al. Cochrane Database Syst Rev. 2014 Sep 18;(9):CD007649. doi: 10.1002/14651858.CD007649.pub3. Cochrane Database Syst Rev. 2014. PMID: 25231904 Updated. Review.
Cited by
- Cyclodextrin-Based Nanogels for Stabilization and Sensing of Curcumin.
Casulli MA, Yan R, Takeuchi S, Cesari A, Mancin F, Hayashita T, Hashimoto T, Taurino I. Casulli MA, et al. ACS Appl Nano Mater. 2024 Aug 27;7(17):20153-20162. doi: 10.1021/acsanm.4c02972. eCollection 2024 Sep 13. ACS Appl Nano Mater. 2024. PMID: 39296865 - The analgesic effect of curcumin and nano-curcumin in clinical and preclinical studies: a systematic review and meta-analysis.
Hajimirzaei P, Eyni H, Razmgir M, Abolfazli S, Pirzadeh S, Ahmadi Tabatabaei FS, Vasigh A, Yazdanian N, Ramezani F, Janzadeh A, Butler AE, Sahebkar A. Hajimirzaei P, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug 26. doi: 10.1007/s00210-024-03369-0. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39186190 Review. - COVID-19-Associated Sepsis: Potential Role of Phytochemicals as Functional Foods and Nutraceuticals.
de Souza Goncalves B, Sangani D, Nayyar A, Puri R, Irtiza M, Nayyar A, Khalyfa A, Sodhi K, Pillai SS. de Souza Goncalves B, et al. Int J Mol Sci. 2024 Aug 3;25(15):8481. doi: 10.3390/ijms25158481. Int J Mol Sci. 2024. PMID: 39126050 Free PMC article. Review. - Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer.
Li Y, Xu C, Han H, Pascual-Sabater S, Fillat C, Goel A. Li Y, et al. Pharmaceuticals (Basel). 2024 Jul 9;17(7):911. doi: 10.3390/ph17070911. Pharmaceuticals (Basel). 2024. PMID: 39065761 Free PMC article. - Therapeutic Potential of Plant-Derived Compounds and Plant Extracts in Rheumatoid Arthritis-Comprehensive Review.
Kciuk M, Garg A, Rohilla M, Chaudhary R, Dhankhar S, Dhiman S, Bansal S, Saini M, Singh TG, Chauhan S, Mujwar S, Gielecińska A, Kontek R. Kciuk M, et al. Antioxidants (Basel). 2024 Jun 27;13(7):775. doi: 10.3390/antiox13070775. Antioxidants (Basel). 2024. PMID: 39061843 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical